Lv11
60 积分 2022-08-18 加入
Keeping an ‘eye’ on ocular GVHD
1个月前
已完结
Clinical outcomes of modified busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for T-cell acute lymphoblastic leukemia/lymphoma
1个月前
已完结
Treosulfan-based conditioning strategies in older or frail patients undergoing allogeneic hematopoietic cell transplantation
1个月前
已完结
Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression
1个月前
已完结
Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease
1个月前
已完结
Allogeneic Transplantation for Older Adults
2个月前
已完结
Allogeneic Transplantation for Older Adults
2个月前
已完结
Comparative transcriptome profile of mouse macrophages treated with the RhoA/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)
4个月前
已完结
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP
5个月前
已完结
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults
5个月前
已完结
皖公网安备34019202002308
